INSIGHTS ON QUALITY CONTROL
-
Learn, Confirm, Then Scale: A Leader's Guide To Transforming QC
Legacy lab systems hinder innovation and scalability. Explore a proven approach to modernize QC through cloud-based LIMS, starting with small pilots that validate strategy and reduce risk.
-
A CDMO's Take On Psychedelic Formulation
Psychedelics show therapeutic promise, but face major formulation and regulatory hurdles. Advances in delivery and neuroscience may unlock new mental‑health treatments.
-
Effective Staffing Plans For GMP Drug Manufacturing Facilities
In the manufacturing industry, the proper planning and staffing of GMP facilities and production lines are crucial for efficient operations and successful outcomes.
-
Monitoring, Media Fills, And QC: Demonstrating Sterility Assurance At Your CDMO
CDMO guide on environmental monitoring, media fills, and QC to prove sterility assurance in aseptic manufacturing—key elements of the Contamination Control Strategy beyond facility design.
-
Detection And Quantification Of Amorphous Content In Materials12/30/2024
Complementary analytical techniques like DSC, MDSC, cRHp, DVS, and SolCal accurately quantify amorphous content in pharmaceuticals to ensure stability, compatibility, and efficiency.
-
Enhance Peptide Innovation With A High-Quality Supply Of Building Blocks1/29/2025
To leverage the benefits of peptide therapeutics, identify an experienced chemical material manufacturer that can produce unique peptide building blocks with quality, efficiency, and continuous compliance.
-
Development Of Separation Methods For GLP-1 Synthetic Peptides6/30/2025
Explore a novel HPLC-UV/MS method for analyzing GLP-1 analogs to address critical challenges in peptide separation, impurity detection, and performance for improved reproducibility.
-
Effect Of X-Ray Inspection On Pharmaceutical Products7/23/2024
Explore the use of X-ray inspection systems for the internal examination of pharmaceutical products, particularly non-transparent packaged drugs.
-
Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy2/6/2026
The most common contamination risks in cell therapy manufacturing are open processes that leverage different products, inflexible instruments, labor intensive workflows, lack of in-line monitoring, and zero failure tolerance.
QUALITY CONTROL SOLUTIONS
-
Explore how specialized analytical expertise and advanced instrumentation enable precise nitrosamine testing to help drug developers meet strict and evolving regulatory requirements.
-
Ensure Compliance. Safeguard Sterility. Drive Manufacturing Excellence.
-
Sterility testing is a requirement to confirm that pharmaceutical products purporting to be sterile do not contain viable microorganisms before being released and administered to patients. So, it is vital that the method used for testing medical devices, pharmaceutical products, formulations, tissue materials, and other products is both reliable and accurate.
-
Explore chromatography methods for sample preparation, residual solvent, and impurity analysis, critical steps for Active Pharmaceutical Ingredient (API) quality control.
-
Maintain peak safety and sterility in sensitive environments with advanced isolation technology. Ensure strict compliance and reliable protection during critical, high-stakes processing tasks.